Using genetic data to better understand disease risk factors.

Mendelian randomization for modern data: Integrating data resources to improve accuracy of causal estimates.

NIH-funded research University of Michigan at Ann Arbor · NIH-10906933

This study is exploring a new way to understand how certain genetic factors might influence diseases like Alzheimer's and heart-related issues, and it aims to create easy-to-use tools for researchers to get clearer answers without needing complicated trials.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Michigan at Ann Arbor NIH-funded
Lab location1 site (Ann Arbor, United States)
Project IDNIH-10906933 on NIH RePORTER

What this research studies

This research focuses on a method called Mendelian randomization (MR) that helps estimate the causal effects of risk factors on diseases using genetic data from large studies. By analyzing summary statistics from genome-wide association studies (GWAS), the researchers aim to improve the accuracy of these estimates without needing randomized trials. The project will develop new statistical methods and user-friendly software to help researchers navigate the complexities of MR, particularly addressing biases that can arise from confounding variables. This approach could lead to more reliable insights into the risk factors for diseases like Alzheimer's and cardiometabolic disorders.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals with a family history of diseases such as Alzheimer's or cardiometabolic disorders, as well as those interested in genetic factors influencing their health.

Not a fit: Patients who do not have a genetic predisposition to the conditions being studied may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could provide clearer insights into the causal relationships between genetic factors and diseases, potentially leading to better prevention and treatment strategies.

How similar studies have performed: Previous research using Mendelian randomization has shown promise in identifying causal relationships in various diseases, indicating that this approach is both tested and potentially impactful.

Where this research is happening

Ann Arbor, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Alzheimer's disease riskCardiometabolic DiseaseCardiometabolic Disorder
Last reviewed 2026-06-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.